CYTOKINE MARKET ANALYSIS

Cytokine Market, By Cytokine Type (Tumor Necrosis Factor-TNF, Interleukins-II, Interferons-IFN, Epidermal Growth Factor-EGF, and Other Cytokine Types), By Therapeutic Application (Cancer, Asthma and Airway Inflammation, Arthritis, and Other Therapeutic Applications), and By Geography (North America, Europe, Asia-Pacific, Middle East and Africa, and South America) - Size, Share, Outlook, and Opportunity Analysis, 2022 - 2028

Published In : Sep 2022
Code : CMI5238
Pages :165
Formats :
Excel and PDF
Industry : Pharmaceutical

Market News

Global Cytokine Market: Key Developments

In April 2020, GlaxoSmithKline announced the positive results from the pivotal SYNAPSE study of NUCALA (mepolizumab) in patients with nasal polyps.

In April 2020, Novartis planned to initiate a Phase III clinical trial to study Ilaris (canakinumab) in patients with COVID-19 pneumonia. A trial will examine efficacy of utilizing canakinumab, an interleukin (IL)-1β blocker, to treat a type of severe immune overreaction.

In January 2020, Amgen Inc. announced its collaboration with Guardant Health & Qiagen NV to accelerate the molecular testing for patients with non-small cell lung cancer.

CYTOKINE MARKET ANALYSIS

Market News

Cytokine Market Report Snapshots

EXISTING CLIENTELE